Menu
GeneBe

SKI

SKI proto-oncogene, the group of SKI transcriptional corepressors

Basic information

Region (hg38): 1:2227387-2310213

Links

ENSG00000157933NCBI:6497OMIM:164780HGNC:10896Uniprot:P12755AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Shprintzen-Goldberg syndrome (Definitive), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Strong), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Strong), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Strong), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Definitive), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Supportive), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Shprintzen-Goldberg syndromeADCardiovascularIndividuals have been described with a number of cardiovascular anomalies, including aortic root dilatation, and spontaneous rupture of arterial aneurysms, and surveillance (eg, including echocardiogram) may allow early management, decreasing morbidity and mortalityCardiovascular; Craniofacial; Musculoskeletal; Neurologic23023332

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SKI gene.

  • Shprintzen-Goldberg syndrome (597 variants)
  • Familial thoracic aortic aneurysm and aortic dissection (418 variants)
  • not provided (272 variants)
  • not specified (94 variants)
  • Inborn genetic diseases (26 variants)
  • SKI-related condition (3 variants)
  • Intellectual disability (3 variants)
  • Isolated thoracic aortic aneurysm (3 variants)
  • Disproportionate tall stature (3 variants)
  • Neurodevelopmental disorder (2 variants)
  • See cases (2 variants)
  • Arterial dissection (1 variants)
  • Intellectual disability;Joint laxity (1 variants)
  • Autism spectrum disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SKI gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
339
clinvar
4
clinvar
352
missense
11
clinvar
9
clinvar
353
clinvar
23
clinvar
396
nonsense
4
clinvar
4
start loss
0
frameshift
1
clinvar
1
clinvar
11
clinvar
13
inframe indel
2
clinvar
17
clinvar
19
splice donor/acceptor (+/-2bp)
3
clinvar
3
splice region
11
15
26
non coding
4
clinvar
48
clinvar
19
clinvar
71
Total 14 10 401 410 23

Variants in SKI

This is a list of pathogenic ClinVar variants found in the SKI region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-2228718-G-T not specified Likely benign (Mar 07, 2018)508030
1-2228721-C-T Likely benign (Mar 13, 2018)680378
1-2228725-G-A not specified Likely benign (Jan 16, 2017)392772
1-2228739-G-T not specified Likely benign (Jan 17, 2017)393061
1-2228740-G-GAGCGGC not specified Likely benign (Mar 30, 2017)508459
1-2228748-G-A not specified Likely benign (Jun 07, 2016)386778
1-2228756-C-G Likely benign (Jun 07, 2018)669030
1-2228771-A-AGGC Shprintzen-Goldberg syndrome Uncertain significance (Aug 03, 2020)1009228
1-2228774-C-A Shprintzen-Goldberg syndrome Uncertain significance (Feb 17, 2023)2689993
1-2228774-C-G Shprintzen-Goldberg syndrome Uncertain significance (Dec 02, 2022)651207
1-2228774-C-T Shprintzen-Goldberg syndrome • Familial thoracic aortic aneurysm and aortic dissection Uncertain significance (Dec 16, 2023)520156
1-2228775-G-C Shprintzen-Goldberg syndrome • Familial thoracic aortic aneurysm and aortic dissection Likely benign (Dec 25, 2022)2145648
1-2228776-G-C Shprintzen-Goldberg syndrome Uncertain significance (Aug 14, 2020)1053780
1-2228777-C-T Shprintzen-Goldberg syndrome Uncertain significance (Sep 19, 2022)426734
1-2228778-G-A Familial thoracic aortic aneurysm and aortic dissection Likely benign (Nov 23, 2023)3223051
1-2228779-G-A Uncertain significance (Dec 31, 2019)1215966
1-2228778-G-GGCAGGCGGCC Uncertain significance (May 22, 2018)545922
1-2228781-A-G Familial thoracic aortic aneurysm and aortic dissection Likely benign (Oct 31, 2019)1776127
1-2228785-G-A Uncertain significance (Dec 03, 2019)1304292
1-2228787-C-T Familial thoracic aortic aneurysm and aortic dissection Likely benign (Nov 10, 2022)2447187
1-2228788-C-G Shprintzen-Goldberg syndrome Uncertain significance (Aug 16, 2023)1427506
1-2228790-C-G Familial thoracic aortic aneurysm and aortic dissection Likely benign (Nov 15, 2020)1792210
1-2228792-G-A Uncertain significance (Jun 26, 2019)1306694
1-2228793-C-A Shprintzen-Goldberg syndrome Likely benign (Jul 23, 2022)1285086
1-2228793-C-G Familial thoracic aortic aneurysm and aortic dissection Likely benign (Apr 09, 2022)1796169

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SKIprotein_codingprotein_codingENST00000378536 781425
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.000985125412031254150.0000120
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.513494380.7960.00002884563
Missense in Polyphen93185.760.500651946
Synonymous-4.873002101.430.00001471536
Loss of Function4.40124.50.04090.00000123293

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.0001010.0000996
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001770.0000177
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling. {ECO:0000269|PubMed:19049980}.;
Disease
DISEASE: Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]: A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, mental retardation, developmental delay and learning disabilities. {ECO:0000269|PubMed:23023332, ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24357594, ECO:0000269|PubMed:24736733}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
TGF-Ncore;Olfactory bulb development and olfactory learning;TGF-beta Signaling Pathway;TGF-beta Receptor Signaling;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Notch;Downregulation of SMAD2/3:SMAD4 transcriptional activity;TGF-beta super family signaling pathway canonical;TGF_beta_Receptor;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;BMP receptor signaling;C-MYB transcription factor network;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Signaling by TGF-beta family members;Regulation of nuclear SMAD2/3 signaling (Consensus)

Recessive Scores

pRec
0.152

Haploinsufficiency Scores

pHI
0.208
hipred
Y
hipred_score
0.783
ghis
0.590

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ski
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; embryo phenotype;

Zebrafish Information Network

Gene name
skia
Affected structure
bulbus arteriosus
Phenotype tag
abnormal
Phenotype quality
amorphous

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;neural tube closure;lens morphogenesis in camera-type eye;transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;cell population proliferation;negative regulation of cell population proliferation;anterior/posterior axis specification;negative regulation of Schwann cell proliferation;myotube differentiation;olfactory bulb development;myelination in peripheral nervous system;positive regulation of Wnt signaling pathway;embryonic limb morphogenesis;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of histone deacetylation;negative regulation of activin receptor signaling pathway;somatic stem cell population maintenance;camera-type eye development;positive regulation of DNA binding;nose morphogenesis;negative regulation of cell differentiation;negative regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;negative regulation of fibroblast proliferation;camera-type eye morphogenesis;neuron development;skeletal muscle fiber development;cell motility;roof of mouth development;retina development in camera-type eye;face morphogenesis;bone morphogenesis;SMAD protein signal transduction;protein homotrimerization
Cellular component
nucleus;nucleoplasm;transcription factor complex;cytoplasm;centrosome;nuclear body;PML body;transcriptional repressor complex;protein-containing complex
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;protein binding;zinc ion binding;protein kinase binding;protein domain specific binding;ubiquitin protein ligase binding;SMAD binding;histone deacetylase inhibitor activity;repressing transcription factor binding